threonine has been researched along with 2019 Novel Coronavirus Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 6 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, R; Alugubelli, YR; Blankenship, LR; Cho, CC; Geng, ZZ; Ji, H; Khatua, K; Li, P; Liu, WR; Ma, XR; Ma, Y; Sankaran, B; Shaabani, N; Vatansever, EC; Xiao, J; Xu, S; Yang, KS; Yu, G | 1 |
| Adachi, M; Chujo, T; Kakizoe, Y; Kaneko, H; Kunisawa, A; Kuratsu, JI; Matsuoka, M; Mizobe, T; Mukoyama, M; Nagata, H; Nagayoshi, Y; Nakamori, Y; Nakata, H; Nishiguchi, K; Oshiumi, H; Sakakida, K; Shimada, S; Tomizawa, K; Wei, FY; Yamamoto, K; Yamamura, R | 1 |
| Aguet, F; Anand, SK; Beausoleil, SA; Blenis, J; Bulaon, DK; Burke, KN; Cantley, LC; Chaparian, RR; Chen, S; Cohen, BM; Davidson, AD; Elemento, O; Getz, G; Hamele, CE; Harding, AT; He, L; Heaton, BE; Heaton, NS; Heesom, K; Hornbeck, PV; Johnson, JL; Jordan, TX; Kastenhuber, ER; Kavanagh-Williamson, M; Kerelsky, A; Koundouros, N; Lee, G; Levy, TM; Liberatore, KM; Lin, TY; Matthews, DA; Mercadante, MN; Nilsson-Payant, BE; Piskounova, E; Possemato, AP; Schwartz, RE; Shobana-Ganesh, K; Smith, CM; Tata, A; Tata, PR; tenOever, BR; Tkachev, SL; Trimarco, JD; Van Nest, SJ; Weinstein, H; Yaron, TM; Zhu, X | 1 |
| Dregni, AJ; Duan, P; Hong, M; Medeiros-Silva, J; Somberg, NH | 1 |
| Bajpai, M; Hora, S; Javed, M; Kale, P; Kashyap, M; Maras, JS; Pahwa, P; Ramakrishna, G; Rathore, A; Sarin, SK; Saxena, A; Sevak, JK; Siddiqui, H; Singh, R; Trehanpati, N; Tyagi, S; Yadav, P | 1 |
| Jeon, YJ; Kim, Y; Lee, S; Manavalan, B; Pham, NT; Phan, LT; Seo, J; Song, M | 1 |
6 other study(ies) available for threonine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals.
Topics: Aldehydes; Antiviral Agents; Coronavirus 3C Proteases; COVID-19; Humans; Protease Inhibitors; SARS-CoV-2; Threonine | 2022 |
t
Topics: Adenosine; Biomarkers; COVID-19; Humans; Nucleosides; RNA; SARS-CoV-2; Threonine | 2022 |
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication.
Topics: Animals; COVID-19; Glycogen Synthase Kinase 3; Humans; Mammals; Nucleocapsid; Nucleocapsid Proteins; Phosphorylation; Protein Serine-Threonine Kinases; SARS-CoV-2; Serine; Threonine; Virus Replication | 2022 |
Atomic structure of the open SARS-CoV-2 E viroporin.
Topics: COVID-19; Humans; Ion Transport; SARS-CoV-2; Threonine; Viroporin Proteins | 2023 |
Metabolic alterations unravel the maternofetal immune responses with disease severity in pregnant women infected with SARS-CoV-2.
Topics: COVID-19; Cytokines; Female; Glycine; Humans; Immunity; Infant, Newborn; Interferon-alpha; Interleukin-6; Interleukin-9; Lactates; NAD; Patient Acuity; Pregnancy; Pregnant Women; Pyruvates; Riboflavin; SARS-CoV-2; Serine; Threonine | 2023 |
Advancing the accuracy of SARS-CoV-2 phosphorylation site detection via meta-learning approach.
Topics: COVID-19; Humans; Phosphorylation; SARS-CoV-2; Serine; Threonine | 2023 |